Treatment Patterns, Goals, and Decision-Making Criteria for Second- and Third-Line Therapies for Multiple Myeloma in Germany
The results suggest that in the absence of a single standard of care for RRMM, prescribers made patient-centred choices of regimens with efficacy as the main goal of therapy.
Authors
- Franziska Ertel (ORCID: https://orcid.org/0009-0006-6970-303X)
- T. Steinmetz (ORCID: https://orcid.org/0000-0001-8580-3109)
- Katherine Houghton (ORCID: https://orcid.org/0000-0003-4416-6080)
- Carmen Flossmann
- Beate Brinkmann
- Tram Nham
Institutions
- RTI Health Solutions (US)
- Amgen (Germany) (DE)
- Praxis für Hämatologie und Onkologie (DE)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1007/s12325-025-03248-x
- Citations
- 2
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54